首页 > 最新文献

Vascular Health and Risk Management最新文献

英文 中文
Cross-Sectional Relationship Between Atrial Conduction Delay and Arterial Stiffness in Patients with Obstructive Sleep Apnea 阻塞性睡眠呼吸暂停患者心房传导延迟与动脉僵硬的横断面关系
Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-11-01 DOI: 10.2147/vhrm.s428713
Azusa Ueda, Satoshi Kasagi, Ken-ichi Maeno, Ryo Naito, Takiko Kumagai, Yuka Kimura, Mitsue Kato, Fusae Kawana, Yasuhiro Tomita, Koji Narui, Takatoshi Kasai
{"title":"Cross-Sectional Relationship Between Atrial Conduction Delay and Arterial Stiffness in Patients with Obstructive Sleep Apnea","authors":"Azusa Ueda, Satoshi Kasagi, Ken-ichi Maeno, Ryo Naito, Takiko Kumagai, Yuka Kimura, Mitsue Kato, Fusae Kawana, Yasuhiro Tomita, Koji Narui, Takatoshi Kasai","doi":"10.2147/vhrm.s428713","DOIUrl":"https://doi.org/10.2147/vhrm.s428713","url":null,"abstract":"","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"70 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135715462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular Health Promotion Project and Vascular Medicine in China-CCVM2004-2023 中国血管健康促进项目与血管医学ccvm2004 -2023
Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-11-01 DOI: 10.2147/vhrm.s432656
Fang Wen, Shantong Jiang, Ping Yuan, Jinbo Liu, Xiu Bai, Hongwei Zhao, Xin Chen, Yan-Bing Gong, Roland Asmar, Hongyu Wang
Abstract: Cardiovascular disease(CVD) has become a major disease burden affecting people’s health in China. Blood vessels are very important for human health and are the “sentinel” for the development of many cardiovascular and cerebrovascular diseases. The key to effectively preventing fatal, disabling heart, brain and peripheral vascular events lies in controlling traditional and non-traditional risk factors for vascular health from the source, and early assessment and intervention of early vascular lesions. Since 2004, China government promoted the early detection technology of vascular lesions and vascular medicine, and proposed the Beijing Vascular Health Stratification (BVHS) to provide suggestions for the examination, evaluation and management of risk factors, and to provide new ideas for lifelong maintenance of vascular health. This review mainly introduces the establishment and development of the clinical discipline of “vascular medicine” in the past 20 years in China, introduces the indicators for detecting vascular function and structure and the predictive value of vascular events, and carries out intelligent and digital management of vascular health throughout the life cycle of individualized prevention, treatment and rehabilitation for people with different parts or degrees of lesions, effectively reducing the occurrence and development of cardiovascular and cerebrovascular diseases, and the prospect of new technology in maintaining vascular health. Keywords: heart and vascular health, vascular medicine, early assessment, digital, Beijing vascular health stratification
摘要:心血管疾病(CVD)已成为影响中国人民健康的主要疾病负担。血管对人体健康非常重要,是许多心脑血管疾病发展的“哨兵”。有效预防致死性、致残性心、脑及外周血管事件的关键在于从源头上控制影响血管健康的传统和非传统危险因素,并对早期血管病变进行早期评估和干预。2004年以来,中国政府推动血管病变早期检测技术和血管医学,提出北京血管健康分层(BVHS),为危险因素的检查、评估和管理提供建议,为血管终身健康的维护提供新思路。本文主要介绍了中国近20年来“血管医学”临床学科的建立和发展,介绍了检测血管功能和结构的指标以及血管事件的预测价值,对不同部位或程度病变人群进行个体化预防、治疗和康复的血管健康全生命周期的智能化、数字化管理。有效减少心脑血管疾病的发生和发展,以及维持血管健康新技术的前景。关键词:心脏与血管健康,血管医学,早期评估,数字化,北京血管健康分层
{"title":"Vascular Health Promotion Project and Vascular Medicine in China-CCVM2004-2023","authors":"Fang Wen, Shantong Jiang, Ping Yuan, Jinbo Liu, Xiu Bai, Hongwei Zhao, Xin Chen, Yan-Bing Gong, Roland Asmar, Hongyu Wang","doi":"10.2147/vhrm.s432656","DOIUrl":"https://doi.org/10.2147/vhrm.s432656","url":null,"abstract":"Abstract: Cardiovascular disease(CVD) has become a major disease burden affecting people’s health in China. Blood vessels are very important for human health and are the “sentinel” for the development of many cardiovascular and cerebrovascular diseases. The key to effectively preventing fatal, disabling heart, brain and peripheral vascular events lies in controlling traditional and non-traditional risk factors for vascular health from the source, and early assessment and intervention of early vascular lesions. Since 2004, China government promoted the early detection technology of vascular lesions and vascular medicine, and proposed the Beijing Vascular Health Stratification (BVHS) to provide suggestions for the examination, evaluation and management of risk factors, and to provide new ideas for lifelong maintenance of vascular health. This review mainly introduces the establishment and development of the clinical discipline of “vascular medicine” in the past 20 years in China, introduces the indicators for detecting vascular function and structure and the predictive value of vascular events, and carries out intelligent and digital management of vascular health throughout the life cycle of individualized prevention, treatment and rehabilitation for people with different parts or degrees of lesions, effectively reducing the occurrence and development of cardiovascular and cerebrovascular diseases, and the prospect of new technology in maintaining vascular health. Keywords: heart and vascular health, vascular medicine, early assessment, digital, Beijing vascular health stratification","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"46 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135715100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of Nigella sativa and Ginger as Appetite Suppressants: An Experimental Study on Healthy Wistar Rats [Letter]. Nigella sativa和Ginger作为食欲抑制剂的效果:对健康Wistar大鼠的实验研究[信]。
IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-10-24 eCollection Date: 2023-01-01 DOI: 10.2147/VHRM.S423812
Adam Arditya Fajriawan, Risqa Novita
{"title":"The Effectiveness of <i>Nigella sativa</i> and Ginger as Appetite Suppressants: An Experimental Study on Healthy Wistar Rats [Letter].","authors":"Adam Arditya Fajriawan, Risqa Novita","doi":"10.2147/VHRM.S423812","DOIUrl":"10.2147/VHRM.S423812","url":null,"abstract":"","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"689-690"},"PeriodicalIF":2.6,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71414059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension. RGS5作为周细胞的生物标志物,参与血管重塑和肺动脉高压。
IF 2.9 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-10-20 eCollection Date: 2023-01-01 DOI: 10.2147/VHRM.S429535
Guofang Lu, Rui Du, Yali Liu, Shumiao Zhang, Juan Li, Jianming Pei

Introduction: Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by a sustained rise in mean pulmonary artery pressure. Pulmonary vascular remodeling serves an important role in PAH. Identifying a key driver gene to regulate vascular remodeling of the pulmonary microvasculature is critical for PAH management.

Methods: Differentially expressed genes were identified using the Gene Expression Omnibus (GEO) GSE117261, GSE48149, GSE113439, GSE53408 and GSE16947 datasets. A co-expression network was constructed using weighted gene co-expression network analysis. Novel and key signatures of PAH were screened using four algorithms, including weighted gene co-expression network analysis, GEO2R analysis, support vector machines recursive feature elimination and robust rank aggregation rank analysis. Regulator of G-protein signaling 5 (RGS5), a pro-apoptotic/anti-proliferative protein, which regulate arterial tone and blood pressure in vascular smooth muscle cells. The expression of RGS5 was determined using reverse transcription-quantitative PCR (RT-qPCR) in PAH and normal mice. The location of RGS5 and pericytes was detected using immunofluorescence.

Results: Compared with that in the normal group, RGS5 expression was upregulated in the PAH group based on GEO and RT-qPCR analyses. RGS5 expression in single cells was enriched in pericytes in single-cell RNA sequencing analysis. RGS5 co-localization with pericytes was detected in the pulmonary microvasculature of PAH.

Conclusion: RGS5 regulates vascular remodeling of the pulmonary microvasculature and the occurrence of PAH through pericytes, which has provided novel ideas and strategies regarding the occurrence and innovative treatment of PAH.

引言:肺动脉高压(PAH)是一种危及生命的疾病,其特征是平均肺动脉压持续升高。肺血管重构在PAH中起着重要作用。确定一个调节肺微血管血管重塑的关键驱动基因对PAH的管理至关重要。方法:使用基因表达综合(GEO)GSE117261、GSE48149、GSE113439、GSE53408和GSE16947数据集鉴定差异表达基因。使用加权基因共表达网络分析构建共表达网络。使用四种算法筛选PAH的新特征和关键特征,包括加权基因共表达网络分析、GEO2R分析、支持向量机递归特征消除和鲁棒秩聚合秩分析。G蛋白信号传导调节因子5(RGS5),一种促凋亡/抗增殖蛋白,调节血管平滑肌细胞的动脉张力和血压。使用逆转录定量PCR(RT-qPCR)测定RGS5在PAH和正常小鼠中的表达。用免疫荧光法检测RGS5和周细胞的位置。结果:根据GEO和RT-qPCR分析,与正常组相比,PAH组RGS5的表达上调。在单细胞RNA测序分析中,RGS5在单细胞中的表达在周细胞中富集。结论:RGS5通过周细胞调节肺微血管的血管重塑和PAH的发生,为PAH的发病和创新治疗提供了新的思路和策略。
{"title":"RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension.","authors":"Guofang Lu,&nbsp;Rui Du,&nbsp;Yali Liu,&nbsp;Shumiao Zhang,&nbsp;Juan Li,&nbsp;Jianming Pei","doi":"10.2147/VHRM.S429535","DOIUrl":"10.2147/VHRM.S429535","url":null,"abstract":"<p><strong>Introduction: </strong>Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by a sustained rise in mean pulmonary artery pressure. Pulmonary vascular remodeling serves an important role in PAH. Identifying a key driver gene to regulate vascular remodeling of the pulmonary microvasculature is critical for PAH management.</p><p><strong>Methods: </strong>Differentially expressed genes were identified using the Gene Expression Omnibus (GEO) GSE117261, GSE48149, GSE113439, GSE53408 and GSE16947 datasets. A co-expression network was constructed using weighted gene co-expression network analysis. Novel and key signatures of PAH were screened using four algorithms, including weighted gene co-expression network analysis, GEO2R analysis, support vector machines recursive feature elimination and robust rank aggregation rank analysis. Regulator of G-protein signaling 5 (RGS5), a pro-apoptotic/anti-proliferative protein, which regulate arterial tone and blood pressure in vascular smooth muscle cells. The expression of RGS5 was determined using reverse transcription-quantitative PCR (RT-qPCR) in PAH and normal mice. The location of RGS5 and pericytes was detected using immunofluorescence.</p><p><strong>Results: </strong>Compared with that in the normal group, RGS5 expression was upregulated in the PAH group based on GEO and RT-qPCR analyses. RGS5 expression in single cells was enriched in pericytes in single-cell RNA sequencing analysis. RGS5 co-localization with pericytes was detected in the pulmonary microvasculature of PAH.</p><p><strong>Conclusion: </strong>RGS5 regulates vascular remodeling of the pulmonary microvasculature and the occurrence of PAH through pericytes, which has provided novel ideas and strategies regarding the occurrence and innovative treatment of PAH.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"673-688"},"PeriodicalIF":2.9,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/ba/vhrm-19-673.PMC10596204.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50162978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Some Risk Factors on Over-Anticoagulation Disorders and Bleeding in Patients Receiving Anticoagulant Therapy with Overdosage of Vitamin K Antagonist. 一些危险因素对维生素K拮抗剂过量抗凝治疗患者过度抗凝障碍和出血的影响。
IF 2.9 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-10-18 eCollection Date: 2023-01-01 DOI: 10.2147/VHRM.S410497
Si Dung Chu, Minh Thi Tran

Objective: Study on effect of risk factors on over-anticoagulation in patients taking anticoagulant drugs with VKAs (vitamin K antagonists).

Methods: Cross-sectional descriptive, prospective research. Study on 79 patients taking anticoagulant drugs with VKAs who had an INR (International Normalized Ratio) index of more than indicated anticoagulation dose with VKAs therapy.

Results: A total of 79 patients, mean age 65.65 ± 12.17 years [33:85], the elderly group is common (73.4%). Patients had hemorrhage disorders account for 22.8%. The INR index had an average value was 5.88 ± 3.0 [3.02-23.95]; The INR> 5 level group is a higher risk of bleeding than the INR ≤5 level group, it's the statistical significance (p < 0.001). The risk factors such as drugs to treat dyslipidemia, hyperthyroid, amiodarone, beta blocker, prednisone, NSAIDs (Non-steroidal anti-inflammatory), BMI (Body Mass Index), smoke and alcohol that the risk factors of increasing of bleeding when receiving anticoagulants but it's not statistically significant yet (OR >1, p > 0.05); These patients using coenzyme Q10 and green vegetable nutrition such as cruciferous vegetables (Brassicaceae, Asteraceae) are quite common (31.6% and 35.4%), its effect on coagulation with vitamin K and cause of the increased in risk of bleeding was statistical significantly with OR = 5.28 (CI: 1.72-16.17, p < 0.01), and OR = 2.99 (CI: 1.01-8.80, p < 0.05) respectively.

Conclusion: Most patients in over-anticoagulation were the elderly group. Patients had hemorrhage disorders account for 22.8%. The INR> 5 level group was a higher risk of bleeding than the INR ≤5 level group with statistical significance. Patients using Coenzyme Q10 and green vegetable nutrition such as cruciferous vegetables (Brassicaceae, Asteraceae) are quite common, its effect on coagulation and cause of the increased risk of bleeding complication with statistical significance.

目的:研究服用维生素K拮抗剂(VKAs)抗凝药物患者过度抗凝的危险因素。方法:横断面描述性、前瞻性研究。对79名服用抗凝血药物的VKAs患者的研究,这些患者的INR(国际标准化比值)指数超过了VKAs治疗的抗凝剂量。结果:共有79例患者,平均年龄65.65±12.17岁[33:85],老年组常见(73.4%),出血性疾病患者占22.8%,INR指数平均值为5.88±3.0[3.02-23.95];INR>5水平组出血风险高于INR≤5水平组,具有统计学意义(p<0.001)。治疗血脂异常、甲状腺功能亢进、胺碘酮、β受体阻滞剂、泼尼松、非甾体抗炎药、BMI,吸烟和饮酒是服用抗凝剂时出血增加的危险因素,但尚不具有统计学意义(OR>1,p>0.05);这些使用辅酶Q10和十字花科蔬菜(十字花科、菊科)等绿色蔬菜营养的患者相当常见(31.6%和35.4%),其对维生素K凝血的影响和出血风险增加的原因具有统计学意义,分别为OR=5.28(CI:1.72-16.17,p<0.01)和OR=2.99(CI:1.01-8.80,p<0.05)。结论:抗凝过度患者多为老年人。出血性疾病患者占22.8%,INR>5水平组出血风险高于INR<5水平组,具有统计学意义。患者使用辅酶Q10和绿色蔬菜营养如十字花科蔬菜(十字花科、菊科)是相当常见的,其对凝血的影响和引起出血并发症的风险增加具有统计学意义。
{"title":"Effect of Some Risk Factors on Over-Anticoagulation Disorders and Bleeding in Patients Receiving Anticoagulant Therapy with Overdosage of Vitamin K Antagonist.","authors":"Si Dung Chu,&nbsp;Minh Thi Tran","doi":"10.2147/VHRM.S410497","DOIUrl":"10.2147/VHRM.S410497","url":null,"abstract":"<p><strong>Objective: </strong>Study on effect of risk factors on over-anticoagulation in patients taking anticoagulant drugs with VKAs (vitamin K antagonists).</p><p><strong>Methods: </strong>Cross-sectional descriptive, prospective research. Study on 79 patients taking anticoagulant drugs with VKAs who had an INR (International Normalized Ratio) index of more than indicated anticoagulation dose with VKAs therapy.</p><p><strong>Results: </strong>A total of 79 patients, mean age 65.65 ± 12.17 years [33:85], the elderly group is common (73.4%). Patients had hemorrhage disorders account for 22.8%. The INR index had an average value was 5.88 ± 3.0 [3.02-23.95]; The INR> 5 level group is a higher risk of bleeding than the INR ≤5 level group, it's the statistical significance (p < 0.001). The risk factors such as drugs to treat dyslipidemia, hyperthyroid, amiodarone, beta blocker, prednisone, NSAIDs (Non-steroidal anti-inflammatory), BMI (Body Mass Index), smoke and alcohol that the risk factors of increasing of bleeding when receiving anticoagulants but it's not statistically significant yet (OR >1, p > 0.05); These patients using coenzyme Q10 and green vegetable nutrition such as cruciferous vegetables (Brassicaceae, Asteraceae) are quite common (31.6% and 35.4%), its effect on coagulation with vitamin K and cause of the increased in risk of bleeding was statistical significantly with OR = 5.28 (CI: 1.72-16.17, p < 0.01), and OR = 2.99 (CI: 1.01-8.80, p < 0.05) respectively.</p><p><strong>Conclusion: </strong>Most patients in over-anticoagulation were the elderly group. Patients had hemorrhage disorders account for 22.8%. The INR> 5 level group was a higher risk of bleeding than the INR ≤5 level group with statistical significance. Patients using Coenzyme Q10 and green vegetable nutrition such as cruciferous vegetables (Brassicaceae, Asteraceae) are quite common, its effect on coagulation and cause of the increased risk of bleeding complication with statistical significance.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"663-672"},"PeriodicalIF":2.9,"publicationDate":"2023-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/c2/vhrm-19-663.PMC10590587.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49692673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]. 息肉病的益处:依从性和时间治疗[回复信函]。
IF 2.9 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-10-13 eCollection Date: 2023-01-01 DOI: 10.2147/VHRM.S441580
Patricio Lopez-Jaramillo, Jose P Lopez-Lopez
{"title":"The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter].","authors":"Patricio Lopez-Jaramillo,&nbsp;Jose P Lopez-Lopez","doi":"10.2147/VHRM.S441580","DOIUrl":"10.2147/VHRM.S441580","url":null,"abstract":"","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"661-662"},"PeriodicalIF":2.9,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/8d/vhrm-19-661.PMC10581016.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49682911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polypill Brings Benefits to Patients with Cardiovascular Disease, Both Improving Medication Adherence and Demonstrating the Concept of Chronotherapy [Letter]. 息肉给心血管疾病患者带来好处,既能提高药物依从性,又能展示时间疗法的概念[信]。
IF 2.9 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-09-27 eCollection Date: 2023-01-01 DOI: 10.2147/VHRM.S440353
Ling-Ling Zhu, Quan Zhou
{"title":"Polypill Brings Benefits to Patients with Cardiovascular Disease, Both Improving Medication Adherence and Demonstrating the Concept of Chronotherapy [Letter].","authors":"Ling-Ling Zhu,&nbsp;Quan Zhou","doi":"10.2147/VHRM.S440353","DOIUrl":"10.2147/VHRM.S440353","url":null,"abstract":"","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"659-660"},"PeriodicalIF":2.9,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/92/46/vhrm-19-659.PMC10544050.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41103593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Warfarin and Thrombotic Mechanical Aortic Valve - Be Cautious to Avoid Severe Warfarin Drug Interactions in Patients with Suspected Infective Endocarditis after Mechanical Aortic Valve Replacement [Letter]. 华法林和血栓性机械主动脉瓣-机械主动脉瓣置换术后疑似感染性心内膜炎患者应谨慎避免华法林与药物的严重相互作用[信函]。
IF 2.9 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-09-25 eCollection Date: 2023-01-01 DOI: 10.2147/VHRM.S440449
Ling-Ling Zhu, Quan Zhou
{"title":"Warfarin and Thrombotic Mechanical Aortic Valve - Be Cautious to Avoid Severe Warfarin Drug Interactions in Patients with Suspected Infective Endocarditis after Mechanical Aortic Valve Replacement [Letter].","authors":"Ling-Ling Zhu,&nbsp;Quan Zhou","doi":"10.2147/VHRM.S440449","DOIUrl":"https://doi.org/10.2147/VHRM.S440449","url":null,"abstract":"","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"657-658"},"PeriodicalIF":2.9,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/80/a7/vhrm-19-657.PMC10541232.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41136499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thromboprophylaxis in Patients Admitted to the Surgical Ward: Clinical Audit. 外科病房患者的血栓预防:临床审计。
IF 2.9 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-09-22 eCollection Date: 2023-01-01 DOI: 10.2147/VHRM.S418808
Yassin Abdelrahim Abdalla, Arwa Mustafa Kamil, Samya Abbas Abdelrazig Mohamed, Ahmed Hashim Ahmed Mohamed, Eman Khalifa, Mohamed Hamid Abdelsalam Mohamed, Eilaf Eltayeb Abdalla Abdelgadir, Muawiya Dabora, Mohammed Salah Eldin Mohammed Elshikh Awoda

Background: Hospital-acquired thrombosis (HAT) is associated with significant morbidity, mortality, and financial burden globally. Following trusted guidelines for VTE prevention has shown effective, safe, and satisfactory results. This prompts national collaborative efforts to maintain a consensus approach for the safe risk assessment of inpatients and the prescription of thromboprophylaxis.

Objective: This study aimed to detect and estimate deviations from international thromboprophylaxis protocols. The study also aimed to raise the quality of practice and adherence to evidence-based protocols in Alshuhada Teaching Hospital.

Methods: A cross-sectional audit of general surgical inpatients was performed from October 2021 to May 2022. The first cycle was from 1/10/2021 to 21/10/2021, and the second cycle was from 13/5/2022 to 31/5/2022. The target population was adults aged >18 years. Data were collected via an online checklist on two separate occasions. The criteria were based on the NICE guideline for venous thromboembolism in individuals aged over 16 years: "Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NG89".

Results: Forty-five surgical inpatients were included in this study: 20 in the first cycle and 25 in the second cycle. The first-cycle report showed that only 25% of VTE candidates received this regimen. In the second cycle, practice significantly improved, with 92% of admitted patients having their risk assessment tool completed within 24 h of admission. 79% of VTE prophylaxis candidates were prescribed adequate pharmacological prophylaxis within 14 h of admission.

Conclusion: The rate of adequate thromboprophylaxis for inpatients undergoing surgery was very low before clinicians received education on VTE prevention, whereas was evidently high after they had received them. The cause of non-adherence in the pre-intervention phase was a lack of adequate knowledge regarding the magnitude and burden of HAT and the importance of thromboprophylaxis, which has a potential role in preventing the majority of HAT.

背景:医院获得性血栓形成(HAT)在全球范围内与严重的发病率、死亡率和经济负担有关。遵循值得信赖的VTE预防指南已显示出有效、安全和令人满意的结果。这促使各国开展合作,为住院患者的安全风险评估和血栓预防处方保持共识。目的:本研究旨在检测和评估与国际血栓预防方案的偏差。该研究还旨在提高Alshuhada教学医院的实践质量和对循证协议的遵守。方法:对2021年10月至2022年5月的普通外科住院患者进行横断面审计。第一个周期为2021年1月10日至2021年10月21日,第二个周期为2022年5月13日至2022年5日31日。目标人群为年龄>18岁的成年人。数据是在两个不同的场合通过在线检查表收集的。该标准基于NICE关于16岁以上患者静脉血栓栓塞的指南:“降低医院获得性深静脉血栓形成或肺栓塞NG89的风险”。结果:本研究包括45名外科住院患者:20名在第一周期,25名在第二周期。第一个周期的报告显示,只有25%的VTE候选人接受了这种方案。在第二个周期中,实践显著改善,92%的入院患者在入院后24小时内完成了风险评估工具。79%的VTE预防候选药物在入院后14小时内得到足够的药物预防。结论:在临床医生接受VTE预防教育之前,接受手术的住院患者的充分血栓预防率非常低,而在他们接受VTE教育之后,充分血栓预防的比率明显较高。干预前阶段不依从性的原因是缺乏对HAT的程度和负担以及血栓预防的重要性的充分了解,血栓预防在预防大多数HAT方面具有潜在作用。
{"title":"Thromboprophylaxis in Patients Admitted to the Surgical Ward: Clinical Audit.","authors":"Yassin Abdelrahim Abdalla,&nbsp;Arwa Mustafa Kamil,&nbsp;Samya Abbas Abdelrazig Mohamed,&nbsp;Ahmed Hashim Ahmed Mohamed,&nbsp;Eman Khalifa,&nbsp;Mohamed Hamid Abdelsalam Mohamed,&nbsp;Eilaf Eltayeb Abdalla Abdelgadir,&nbsp;Muawiya Dabora,&nbsp;Mohammed Salah Eldin Mohammed Elshikh Awoda","doi":"10.2147/VHRM.S418808","DOIUrl":"https://doi.org/10.2147/VHRM.S418808","url":null,"abstract":"<p><strong>Background: </strong>Hospital-acquired thrombosis (HAT) is associated with significant morbidity, mortality, and financial burden globally. Following trusted guidelines for VTE prevention has shown effective, safe, and satisfactory results. This prompts national collaborative efforts to maintain a consensus approach for the safe risk assessment of inpatients and the prescription of thromboprophylaxis.</p><p><strong>Objective: </strong>This study aimed to detect and estimate deviations from international thromboprophylaxis protocols. The study also aimed to raise the quality of practice and adherence to evidence-based protocols in Alshuhada Teaching Hospital.</p><p><strong>Methods: </strong>A cross-sectional audit of general surgical inpatients was performed from October 2021 to May 2022. The first cycle was from 1/10/2021 to 21/10/2021, and the second cycle was from 13/5/2022 to 31/5/2022. The target population was adults aged >18 years. Data were collected via an online checklist on two separate occasions. The criteria were based on the NICE guideline for venous thromboembolism in individuals aged over 16 years: \"Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NG89\".</p><p><strong>Results: </strong>Forty-five surgical inpatients were included in this study: 20 in the first cycle and 25 in the second cycle. The first-cycle report showed that only 25% of VTE candidates received this regimen. In the second cycle, practice significantly improved, with 92% of admitted patients having their risk assessment tool completed within 24 h of admission. 79% of VTE prophylaxis candidates were prescribed adequate pharmacological prophylaxis within 14 h of admission.</p><p><strong>Conclusion: </strong>The rate of adequate thromboprophylaxis for inpatients undergoing surgery was very low before clinicians received education on VTE prevention, whereas was evidently high after they had received them. The cause of non-adherence in the pre-intervention phase was a lack of adequate knowledge regarding the magnitude and burden of HAT and the importance of thromboprophylaxis, which has a potential role in preventing the majority of HAT.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"651-656"},"PeriodicalIF":2.9,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/a6/vhrm-19-651.PMC10521924.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41158441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suboptimal Knowledge and Care of Patients with Acute Coronary Syndrome Among Nurses Working in Selected Hospitals in Addis Ababa, Ethiopia 2021. 2021年埃塞俄比亚亚的斯亚贝巴选定医院护士对急性冠状动脉综合征患者的次优知识和护理。
IF 2.9 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2023-09-21 eCollection Date: 2023-01-01 DOI: 10.2147/VHRM.S422339
Bizuayehu Ashine Lakew, Daniel M Bekele, Wudma Alemu Kassa, Boka Dugassa Tolera

Background: Acute Coronary Syndrome is the leading cause of morbidity and mortality in developing nations including Ethiopia. As frontline healthcare providers, nurses need to be prudent in handling cases of acute coronary syndrome. However, nurses' knowledge and practice of acute coronary syndrome are not well-known across Ethiopia. Thus, this study aimed to assess knowledge, practice, and associated factors regarding the care of acute coronary syndrome among acute care nurses working at selected hospitals in Addis Ababa, Ethiopia.

Methods: Institution-based descriptive cross-sectional study design was conducted from February to March among 252 purposively selected nurses working in tertiary hospitals of Addis Ababa, Ethiopia. A pretested and structured questionnaire was used for data collection. Data were entered into Epi-Data 4.6 and exported to SPSS version 25. Both descriptive and inferential statistics were used to describe and test the association between selected variables. P-values < 0.05 were declared as significant factors for the outcome variable.

Results: Out of 252 nurses, (52%) had good knowledge, and (44.4%) had good practice towards care of Acute Coronary Syndrome. Being a master's degree [AOR=3.801, (95% CI:1.314-10.996), P =0.014] and having guidelines [AOR= 10.998, (95% CI:2.478-48.805), P =0.002] were significantly associated with nurse's good knowledge of ACS. While having a master's degree [AOR=4.258, (95% CI:1.676-10.820), P=0.002] and getting in-service training [AOR= 1.902, (95% CI:1.022-3.539), P = 0.042] were significantly associated with nurse's good level of practice.

Conclusion: In this study, nurses had inadequate knowledge and practice regarding the care of Acute Coronary Syndrome. Nurses' educational level, presence of clinical practice guidelines, and getting training were determinant factors associated with good knowledge and practice. Therefore, organizational and nursing educational support are needed to improve this gap by providing short- and long-term training, and updated evidence-based clinical practice guidelines should be available for all acute care nurses.

背景:急性冠状动脉综合征是包括埃塞俄比亚在内的发展中国家发病率和死亡率的主要原因。作为一线医疗保健提供者,护士在处理急性冠状动脉综合征病例时需要谨慎。然而,护士对急性冠状动脉综合征的知识和实践在埃塞俄比亚并不为人所知。因此,本研究旨在评估埃塞俄比亚亚的斯亚贝巴选定医院的急性护理护士对急性冠状动脉综合征护理的知识、实践和相关因素,埃塞俄比亚。数据收集采用了经过预测试的结构化问卷。数据输入Epi Data 4.6,并导出到SPSS 25版本。描述性和推断统计学都被用来描述和测试所选变量之间的相关性。P值<0.05被宣布为结果变量的显著因素。结果:252名护士中,52%的护士对急性冠状动脉综合征有良好的认识,44.4%的护士对其护理有良好的实践。具有硕士学位[AOR=3.801,(95%CI:1.314-10.996),P=0.014]和具有指导方针[AOR=10.998,(95%CI:2.478-48.805),P=0.002]与护士对ACS的良好认识显著相关。硕士学位[AOR=4.258,(95%CI:1.676-10.820),P=0.002]和在职培训[AOR=1.902,(95%CI:10.022-3.539),P=0.042]与护士良好的实践水平显著相关。结论:在本研究中,护士对急性冠状动脉综合征的护理知识和实践不足。护士的教育水平、临床实践指南的存在和接受培训是与良好知识和实践相关的决定因素。因此,需要组织和护理教育支持,通过提供短期和长期培训来改善这一差距,并应为所有急性护理护士提供最新的循证临床实践指南。
{"title":"Suboptimal Knowledge and Care of Patients with Acute Coronary Syndrome Among Nurses Working in Selected Hospitals in Addis Ababa, Ethiopia 2021.","authors":"Bizuayehu Ashine Lakew,&nbsp;Daniel M Bekele,&nbsp;Wudma Alemu Kassa,&nbsp;Boka Dugassa Tolera","doi":"10.2147/VHRM.S422339","DOIUrl":"https://doi.org/10.2147/VHRM.S422339","url":null,"abstract":"<p><strong>Background: </strong>Acute Coronary Syndrome is the leading cause of morbidity and mortality in developing nations including Ethiopia. As frontline healthcare providers, nurses need to be prudent in handling cases of acute coronary syndrome. However, nurses' knowledge and practice of acute coronary syndrome are not well-known across Ethiopia. Thus, this study aimed to assess knowledge, practice, and associated factors regarding the care of acute coronary syndrome among acute care nurses working at selected hospitals in Addis Ababa, Ethiopia.</p><p><strong>Methods: </strong>Institution-based descriptive cross-sectional study design was conducted from February to March among 252 purposively selected nurses working in tertiary hospitals of Addis Ababa, Ethiopia. A pretested and structured questionnaire was used for data collection. Data were entered into Epi-Data 4.6 and exported to SPSS version 25. Both descriptive and inferential statistics were used to describe and test the association between selected variables. P-values < 0.05 were declared as significant factors for the outcome variable.</p><p><strong>Results: </strong>Out of 252 nurses, (52%) had good knowledge, and (44.4%) had good practice towards care of Acute Coronary Syndrome. Being a master's degree [AOR=3.801, (95% CI:1.314-10.996), P =0.014] and having guidelines [AOR= 10.998, (95% CI:2.478-48.805), P =0.002] were significantly associated with nurse's good knowledge of ACS. While having a master's degree [AOR=4.258, (95% CI:1.676-10.820), P=0.002] and getting in-service training [AOR= 1.902, (95% CI:1.022-3.539), P = 0.042] were significantly associated with nurse's good level of practice.</p><p><strong>Conclusion: </strong>In this study, nurses had inadequate knowledge and practice regarding the care of Acute Coronary Syndrome. Nurses' educational level, presence of clinical practice guidelines, and getting training were determinant factors associated with good knowledge and practice. Therefore, organizational and nursing educational support are needed to improve this gap by providing short- and long-term training, and updated evidence-based clinical practice guidelines should be available for all acute care nurses.</p>","PeriodicalId":23597,"journal":{"name":"Vascular Health and Risk Management","volume":"19 ","pages":"637-649"},"PeriodicalIF":2.9,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/fa/vhrm-19-637.PMC10519216.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41180070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vascular Health and Risk Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1